Suppr超能文献

支气管胸膜瘘患者脓胸的胸腔内治疗:支气管内瓣膜的新用途

Intrapleural Therapy for Empyema in the Setting of a Bronchopleural Fistula: A Novel Use of an Intrabronchial Valve.

机构信息

Division of Pulmonary and Critical Care, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.

Division of Thoracic Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland.

出版信息

Ann Thorac Surg. 2018 Sep;106(3):e111-e113. doi: 10.1016/j.athoracsur.2018.03.023. Epub 2018 Apr 13.

Abstract

Postsurgical empyema with bronchopleural fistula can be difficult to manage. We present a patient with postoperative empyema with bronchopleural fistula who was successfully treated nonoperatively by placing an intrabronchial valve to address the bronchopleural fistula, which allowed for safe administration of intrapleural fibrinolytics and antibiotics for definitive treatment of the empyema. Although the presence of a bronchopleural fistula is considered a contraindication to the administration of intrapleural tissue plasminogen activator and deoxyribonuclease, this case demonstrates a novel use of the intrabronchial valve that allowed these medications to be used.

摘要

术后脓胸伴支气管胸膜瘘的治疗较为困难。我们报告了一例术后脓胸伴支气管胸膜瘘患者,通过放置支气管内单向活瓣成功地进行了非手术治疗,以解决支气管胸膜瘘问题,从而可以安全地给予胸腔内纤维蛋白溶解酶和抗生素,以对脓胸进行确定性治疗。尽管支气管胸膜瘘的存在被认为是胸腔内组织纤溶酶原激活物和脱氧核糖核酸酶给药的禁忌证,但本病例展示了支气管内单向活瓣的新用途,使这些药物得以应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验